Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
TBTC Study 33/iAdhere: AdherenceC
Study Director
Start Date
9 / 2012
Trial Phase
Trial Status
in data analysis
Current Enrollment
1002
Target Enrollment
1000
Overview
Compound Associations
Rifapentine for Latent TB Infection (LTBI)